Who owns KYTX?
Institutional ownership of Kyverna Therapeutics Inc. from Form 13F, Q2 2026
120 institutional managers reported holding Kyverna Therapeutics Inc. (KYTX) in Form 13F filings for Q2 2026, with 37,594,332 shares worth $335M. The largest reported holder was GordonMD Global Investments LP. Managers that filed both quarters added a net 2,771,036 shares (+8.0%). 31 opened new positions and 21 sold out.
- Funds holding
- 120
- Value held
- $335M
- New / sold out
- 31 / 21
- Net shares, same filers
- +8.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of KYTX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| GordonMD Global Investments LP | $37.8M | 11.3% | 4,244,818 | Unchanged |
| Gilead Sciences, Inc. | $36.8M | 11.0% | 4,126,119 | Unchanged |
| BlackRock, Inc. | $27.9M | 8.3% | 3,134,807 | Added |
| Bain Capital Life Sciences Investors, LLC | $25.7M | 7.7% | 2,885,000 | Trimmed |
| AIGH Capital Management LLC | $24.9M | 7.4% | 2,795,797 | Added |
| Deerfield Management Company, L.p. | $17.8M | 5.3% | 2,000,000 | Unchanged |
| Vanguard Capital Management LLC | $16.9M | 5.0% | 1,897,451 | Added |
| Price T Rowe Associates Inc | $10.6M | 3.2% | 1,186,023 | Trimmed |
| Geode Capital Management, LLC | $9.4M | 2.8% | 1,049,430 | Added |
| Insight Holdings Group, LLC | $8.8M | 2.6% | 989,054 | Unchanged |
| Morgan Stanley | $8.8M | 2.6% | 982,307 | Added |
| State Street Corp | $8.8M | 2.6% | 982,233 | Added |
| Propel Bio Management, LLC | $7.9M | 2.3% | 883,198 | Added |
| Woodline Partners LP | $7.5M | 2.2% | 845,325 | Unchanged |
| Millennium Management LLC | $5.7M | 1.7% | 639,780 | Trimmed |
| MBB Public Markets I LLC | $5.5M | 1.6% | 614,477 | Unchanged |
| Adage Capital Partners GP, L.l.c. | $4.5M | 1.3% | 500,000 | Unchanged |
| D. E. Shaw & Co., Inc. | $4.2M | 1.2% | 469,346 | Trimmed |
| Wells Fargo & Company | $3.3M | 1.0% | 373,009 | Added |
| UBS Group AG | $3.3M | 1.0% | 365,574 | Trimmed |
| Goldman Sachs Group Inc | $3.0M | 0.9% | 335,230 | Added |
| Renaissance Technologies LLC | $3.0M | 0.9% | 333,899 | Trimmed |
| Charles Schwab Investment Management Inc | $2.8M | 0.9% | 319,666 | Added |
| Northern Trust Corp | $2.8M | 0.8% | 315,354 | Added |
| BNP Paribas Financial Markets | $2.8M | 0.8% | 310,632 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 37,594,332 KYTX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$20.1M
- State Street Corp Added+$7.5M
- AIGH Capital Management LLC Added+$7.1M
- Geode Capital Management, LLC Added+$5.6M
- Vanguard Portfolio Management LLC New+$2.5M
- Wells Fargo & Company Added+$2.3M
- Propel Bio Management, LLC Added+$2.1M
- Northern Trust Corp Added+$2.1M
- Nuveen, LLC New+$2.1M
- Bank of America Corp Added+$1.9M
Biggest sellers in Q2 2026
- Balyasny Asset Management L.P. Trimmed-$9.2M
- Marshall Wace, LLP Sold out-$5.2M
- Susquehanna International Group, LLP Trimmed-$3.8M
- Price T Rowe Associates Inc Trimmed-$3.3M
- Millennium Management LLC Trimmed-$3.3M
- D. E. Shaw & Co., Inc. Trimmed-$2.2M
- Bain Capital Life Sciences Investors, LLC Trimmed-$2.0M
- Point72 Asset Management, L.P. Sold out-$1.9M
- Qube Research & Technologies Ltd Trimmed-$1.9M
- Invesco Ltd. Trimmed-$1.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $69.6M and sold $44.6M; 36 added and 28 trimmed.
Schedule 13D and 13G filings on KYTX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-10-19HIRSCHMAN ORIN SCHEDULE 13G filed by Kyverna Therapeutics Inc.Schedule 13G
- 2026-07-29BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
Questions about KYTX ownership
- Who owns KYTX stock?
- 120 institutional investment managers reported KYTX positions in their Form 13F filings for Q2 2026, holding 37,594,332 shares worth $335M in total. GordonMD Global Investments LP reported the largest position.
- Are funds buying or selling KYTX?
- In Q2 2026, 31 managers opened new KYTX positions, 36 added, 28 trimmed and 21 sold out. Managers that filed in both quarters added a net 2,771,036 shares.
- How current is this KYTX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to KYTX by CUSIP. Options are left out. KYTX news and filings · KYTX insider trades · Top funds